Incorporated in 2021, Speciality Medicines Limited is engaged in the marketing and distribution of speciality pharmaceutical formulations. The company focuses on high-value oral and injectable medications used in the treatment of complex chronic conditions, catering to both domestic and international markets.

Its product portfolio includes a diverse range of finished formulations available in multiple dosage forms, such as tablets, capsules, creams, syrups, eye drops, gels, infusions, inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, sachets, and suspensions.

The company operates through two primary business models:

Contract manufacturing of finished formulations for international markets

Marketing and distribution of sourced speciality pharmaceutical products

Speciality Medicines Limited has established an international presence, with products either registered or under registration in countries such as Jordan, Ethiopia, Uganda, Peru, and Namibia. Domestically, it has built a strong distribution network across more than 20 states in India, while also maintaining a global footprint spanning over 35 countries.

As of March 31, 2025, the company had 1 product registered overseas and 60 products under registration across 5 countries, contributing to its revenue pipeline.

As of August 31, 2025, the company employed 18 permanent staff members across various functions.